healthcare
- Home
- healthcare
Public
Research Note - Rise of the Cashless Economy
- Review
- June 3, 2020
Novatti launches new payments platform for purpose-issued Visa cards
- Review
- September 29, 2020
Latest Articles
InteliCare launches aged care remote dashboard to track health of dependants
Continuing to leverage their healthcare technology, InteliCare (ASX: ICR) is furthering its push to give aged care residents privacy and autonomy while ensuring health standards can be maintained where loved ones will be able to track their condition remotely. The launch of InteliLiving health metrics will enable those living independently to have health data uploaded
Read MorePublic
ResApp granted European approval for wearable cough assessment device
Amid the growing concerns around coughing in public for the obvious reason, medtech company ResApp Health (ASX: RAP) has secured regulatory approval in Europe for their wearable device that analyses a person’s cough and the medical implications. The device, which is yet to be named, can be easily clipped on to a person’s shirt where
Read MorePublic
Healthia earnings up 91% as pandemic boosts Aussie health consciousness
As the world emerges from a pandemic, Australians are proving to be more conscious of their general health than ever as evidenced by allied health company Healthia (ASX: HLA) which has delivered shareholders a 91% increase in underlying EBITDA. The bumper result was driven by 14.5% organic growth across the Group whose clinics continue to
Read MorePublic
Healthia eyes off more acquisitions with NAB partnership, increases facility to $70m
Capitalising on favourable economic conditions, allied healthcare company Healthia (ASX: HLA) has partnered with National Australia Bank (ASX: NAB) to increase their finance facility by $20 million which will be deployed towards allied health acquisitions for the rapidly growing service provider. The partnership increases Healthia’s existing finance facility from $50m to $70m and will see
Read MorePublic
MyFiziq inks Tinjoy deal to access 28 million new customers in China
Health tech company MyFiziq (ASX: MYQ) is making rapid inroads into the lucrative health-conscious Chinese market having signed terms with Tinjoy Biotech to secure direct access to their 28 million consumers. The deal will see MyFiziq’s CompleteScan app integrated with Tinjoy’s WinScan Digital Health Platform where MyFiziq will utilise Tinjoy’s call centre of almost 1,000
Read MorePublic
Pharmaxis sales thriving in US following FDA approval for cystic fibrosis treatment
The world’s most lucrative healthcare market is quickly appreciating Aussie pharmaceuticals company Pharmaxis (ASX: PXS) whose cystic fibrosis (CF) treatment Bronchitol is rapidly emerging as the preferred treatment by CF sufferers in the United States. Researched and manufactured in Australia, Bronchitol gained commercial approval from the US Food and Drug Administration (FDA) in October 2020
Read MorePublic